Rockefeller Financial Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$403K Hold
4,768
0.01% 298
2017
Q3
$408K Sell
4,768
-4,804
-50% -$394K 0.01% 277
2017
Q2
$788K Sell
9,572
-2,752
-22% -$225K 0.02% 199
2017
Q1
$1.04M Sell
12,324
-530
-4% -$42.5K 0.02% 190
2016
Q4
$945K Buy
12,854
+6,784
+112% +$505K 0.02% 201
2016
Q3
$487K Hold
6,070
0.01% 241
2016
Q2
$478K Sell
6,070
-229
-4% -$17.2K 0.01% 254
2016
Q1
$454K Buy
6,299
+229
+4% +$17.3K 0.01% 257
2015
Q4
$511K Hold
6,070
0.01% 251
2015
Q3
$508K Sell
6,070
-978
-14% -$82.6K 0.01% 247
2015
Q2
$588K Hold
7,048
0.01% 226
2015
Q1
$512K Hold
7,048
0.01% 243
2014
Q4
$486K Sell
7,048
-1,956
-22% -$132K 0.01% 242
2014
Q3
$584K Sell
9,004
-210
-2% -$13.3K 0.01% 237
2014
Q2
$573K Hold
9,214
0.01% 248
2014
Q1
$542K Sell
9,214
-79
-0.9% -$4.41K 0.01% 248
2013
Q4
$474K Sell
9,293
-10,189
-52% -$510K 0.01% 275
2013
Q3
$981K Sell
19,482
-1,197
-6% -$62.7K 0.02% 229
2013
Q2
$1.02M Buy
+20,679
New +$1.13M 0.02% 215

Other funds holding LLY

Rockefeller Financial Services's LLY Position: Q4 2017 in Review

Rockefeller Financial Services held its Eli Lilly (LLY) position steady in Q4 2017 at 4,768 shares worth $403K. The position accounts for 0.01% of the portfolio, ranked #298.

Rockefeller Financial Services first reported a position in LLY in Q2 2013 and has held it in 19 quarters since. The position peaked at $1.04M in Q1 2017. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • Rockefeller Financial Services held 4,768 shares of Eli Lilly worth $403K as of Q4 2017.
  • Rockefeller Financial Services left its Eli Lilly share count unchanged in Q4 2017.
  • Eli Lilly made up 0.01% of Rockefeller Financial Services's portfolio in Q4 2017, its #298 holding.
  • Rockefeller Financial Services first reported a position in Eli Lilly in Q2 2013 and has held it in 19 quarters since.
  • Rockefeller Financial Services's Eli Lilly position peaked at $1.04M in Q1 2017.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.